Fortress Investment Group’s Centessa Pharmaceuticals CNTA Stock Holding History

Fortress Investment Group’s Portfolio CNTA Stock Details CNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-20,000	Closed	-$794K	–	28
2026 Q1	$794K	Buy	+20,000	New	+$512K	0.2%	27

Fortress Investment Group's CNTA Position: Q2 2026 in Review

Fortress Investment Group sold out of Centessa Pharmaceuticals (CNTA) in Q2 2026, closing a stake of 20,000 shares — an estimated $794K sold.

Fortress Investment Group first reported a position in CNTA in Q1 2026 and held it in 1 quarter. The position peaked at $794K in Q1 2026. 0 funds tracked by Wall St. Rank hold CNTA as of Q2 2026.

Fortress Investment Group reported no remaining Centessa Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Fortress Investment Group sold 20,000 Centessa Pharmaceuticals shares in Q2 2026, an estimated $794K.
Fortress Investment Group first reported a position in Centessa Pharmaceuticals in Q1 2026 and held it in 1 quarter.
Fortress Investment Group's Centessa Pharmaceuticals position peaked at $794K in Q1 2026.
0 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q2 2026.

Based on Fortress Investment Group's 13F filing for Q2 2026, filed 14 Aug 2026.